Keywords
abnormalities abnormality acquisition addition addressing adjunct advanced agreed allowing allows appears application applications assess assessed assessing audience axillary basic become best biopsy breast cancer cancers cautioned chemotherapy clear clinical clinicians conducted confirmed consortium constance controversy cost cover defined describe detect detection diagnose diagnosed diagnosis disease dynamic early edge effectiveness efficacy enhanced established evaluating evaluation exam exclude extensive extent familial findings gain general genetic guidelines harms highlights history identify impact important include indications international last lesions malignancy malignant mammography managing many mastectomy microscopic missed morphology much natl needed newly numerous objectives occult operative otherwise outcomes overrule palpable patient patients percentage pioneered plenary popular populations potential predisposition primary prior published rather recently recognizing recommendation regarding reported reports resolution respectively response risk role scale school screen screening sensitivity since smith society spatial specialty spectrum static studies subsequent subtraction superior target technical technology temporal tended theories title tool transformed treatment trials undertaken unknown women years
